NONQUALIFIED STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2018 INDUCEMENT GRANT PLANNonqualified Stock Option Agreement • December 3rd, 2018 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Altimmune, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the Altimmune, Inc. 2018 Inducement Grant Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and
RESTRICTED STOCK AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLANRestricted Stock Agreement • December 3rd, 2018 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
Subject to the terms and conditions set forth herein, the Committee hereby grants shares of Common Stock as set forth below (the “Shares”) to the Participant, as an Eligible Employee, on (the Grant Date”) pursuant to the Altimmune, Inc. 2017 Omnibus Incentive Plan, as it may be amended from time to time (the “Plan”). Pursuant to Section 2 hereof, the Shares are subject to certain restrictions, which restrictions shall lapse at the times provided under Section 2(c) hereof. While such restrictions are in effect, the Shares subject to such restrictions shall be referred to herein as “Restricted Stock.” Except as otherwise indicated, any capitalized term used but not defined herein shall have the meaning ascribed to such term in the Plan. By signing and returning this Agreement, the Participant acknowledges having received and read a copy of the Plan and agrees to comply with it, this Agreement and all applicable laws and regulations.
GENERAL RELEASEGeneral Release • December 3rd, 2018 • Altimmune, Inc. • Pharmaceutical preparations • Maryland
Capitalized terms used herein but not specifically defined shall have the meanings set forth in the Employment Agreement between the Executive and the Company, dated as of December 7, 2015, as amended by the First Amendment to the Employment Agreement, effective as of January 18, 2017 (together, the “Employment Agreement”).
ALTIMMUNE, INC. CONSULTING AGREEMENTConsulting Agreement • December 3rd, 2018 • Altimmune, Inc. • Pharmaceutical preparations • Maryland
This Consulting Agreement (the “Agreement”) is hereby made and entered into as of the 30th day of November, 2018 (the “Effective Date”), by and between Altimmune, Inc., a Delaware corporation (“Altimmune” or “Company”), having a place of business at 910 Clopper Road, Gaithersburg, Maryland 20878 and William Enright, an individual, residing at and conducting business at 12312 Chagall Dr., N. Potomac, MD 20878 (“Consultant”).
